Studies involving rats demonstrated that MT-2 reduced alcohol consumption while increasing water intake, indicating its potential influence on impulse control and beverage preference
We all get tired after a long day, a demanding week, or a late night
Youll likely start noticing some improvements in your appetite and reduced cravings immediately
Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate
Start With Cost Questions Use these guides to sort out starter prices, medicine costs, visit fees, insurance limits, and public examples like LillyDirect, NovoCare, and Walgreens
This surge presents both a challenge and a profound opportunity: how can fitness and wellness professionals confidently and safely support clients navigating rapid, medication-driven transformation